Abdul Saied

TL;DR: Although randomized controlled trials comparing RFA and MCT for hepatic ablation are lacking, a review of presently available data supports that MCT may be optimal when larger necrosis zones and/or ablation of multiple lesions are the objectives.

TL;DR: The findings from this report exhibit biologic activity and safety of regionally infused CAR-T for an indication with limited immune-oncology success to date and how HAI ofCAR-T may be included in multidisciplinary treatment plans for patients with liver metastases is determined.

TL;DR: The evolution of the most relevant immunotherapies, their mechanisms of action, the data supporting their clinical use, and integration of immunotherapy into multidisciplinary management of solid tumors are summarized.

TL;DR: There is an age-defined underutilization of internet and electronic devices to exchange HRI and CCC among elderly patients with cancer, and characterization of this age-dependent transition zone will enable clinicians to identify patients who may not interface well with electronic communication strategies, and to improve delivery of HRIand CCC for the elderly.

TL;DR: In stage IV CRC, LNR is associated with the extent of hepatic tumor burden and was an independent predictor of survival in patients undergoing liver resection.